Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
Max Heiduk, Ioana Plesca, Jessica M. Gluck, et al.
JCI Insight (2022) Vol. 7, Iss. 22
Open Access | Times Cited: 17

Showing 17 citing articles:

Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 25
Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy
Maozhen Peng, Ying Ying, Zheng Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2448-2448
Open Access | Times Cited: 12
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
Max Heiduk, Anna Klimová, Charlotte Reiche, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 14, pp. 2638-2650
Open Access | Times Cited: 11
Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results
Robert C. Chick, Andrew J. Gunderson, Shafia Rahman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3967-3967
Open Access | Times Cited: 11
IL‐6 mediated CD206+ARG‐1+ tumor associated macrophage polarization induces Treg infiltration in non‐responder luminal A breast cancer
Ananya Das, Sraddhya Roy, Aparajita Bairagi, et al.
FEBS Letters (2025)
Closed Access
Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma
Luise Rupp, Ina Dietsche, Maximilian Kießler, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer
David Digomann, Johannes Strack, Max Heiduk, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2326-2326
Open Access | Times Cited: 9
Single Dual-specific Anti-PD-L1/TGF-β Antibody Synergizes with Chemotherapy as Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma: a Preclinical Experimental Study
Haoxiang Zhang, Jiaoshun Chen, Jianwei Bai, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 5, pp. 2679-2691
Open Access | Times Cited: 2
Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor
Sergio Pedrazzoli
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6461-6461
Open Access | Times Cited: 6
Trametinib potentiates anti-PD-1 efficacy in tumors established from chemotherapy-primed pancreatic cancer cells
Thao D. Pham, Anastasia E. Metropulos, Nida Mubin, et al.
Molecular Cancer Therapeutics (2024), pp. OF1-OF12
Closed Access | Times Cited: 1
Updates in Immunotherapy for Pancreatic Cancer
Robert C. Chick, Timothy M. Pawlik
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6419-6419
Open Access | Times Cited: 1
Current Status and Perspectives of Pancreatic Cancer Tumor Microenvironment and Therapy
Xinyue Guo, Zheng Jiang
International Journal of Frontiers in Medicine (2024) Vol. 6, Iss. 2
Open Access
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
David Digomann, Max Heiduk, Charlotte Reiche, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Data from TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
Max Heiduk, Anna Klimová, Charlotte Reiche, et al.
(2023)
Open Access
Data from TIGIT expression delineates T cell populations with distinct functional and prognostic impact in pancreatic cancer
Max Heiduk, Anna Klimová, Charlotte Reiche, et al.
(2023)
Open Access
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
Eline S. Zwart, Thomas van Ee, Deesje Doppenberg, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 14731-14743
Open Access
Page 1

Scroll to top